Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Wiad Parazytol ; 48(3): 263-9, 2002.
Article in Polish | MEDLINE | ID: mdl-16888971

ABSTRACT

Pregnancy is considered a factor of vulvovaginal mycosis. Secretion of hydrolases is an important determinant of Candida virulence. Thus, the aim of the study was to found the relationship between activity of 19 hydrolases in fungi isolated from vagina of pregnant women and symptoms of mycosis. 251 pregnant women were examined. Samples were collected from vagina and cultured on Sabouraud media. Activity of hydrolytic enzymes was evaluated using API ZYM (bioMerieux) test Fungi were found in 20.1% of vaginal samples. Symptoms were detected in 45.8% of women. Only 32.1% of women with discharge and 26.4% with pruritus had mycosis. Out of the 19 examined hydrolazes, 13 active enzymes were detected in fungal strains. We found for the first time the relationship between activity of fungal esterase lipase and the presence of vaginal discharge in pregnant women.


Subject(s)
Candida/enzymology , Candidiasis, Vulvovaginal/diagnosis , Candidiasis, Vulvovaginal/parasitology , Hydrolases/metabolism , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/parasitology , Candida/isolation & purification , Candida/pathogenicity , Female , Humans , Mycological Typing Techniques/methods , Poland , Pregnancy , Pruritus Vulvae/diagnosis , Pruritus Vulvae/parasitology , Vaginal Discharge/diagnosis , Vaginal Discharge/parasitology
2.
Wiad Lek ; 45(7-8): 263-9, 1992 Apr.
Article in Polish | MEDLINE | ID: mdl-1462586

ABSTRACT

The microbiological effectiveness of the preparation Gynalgin produced by POLFA Pharmaceutical Works in Rzeszów was assessed in cases of vulvovaginitis in 55 patients with clinically diagnosed inflammatory conditions of the lower genital tract, who were given Gynalgin tablets in 10-day courses. Vaginal smears were examined three times for the presence of bacteria, fungi and trichomonas vaginalis (before and immediately after the treatment, and two weeks later). In the initial examination in five vaginal smears mixed bacterial flora was found, in 6 smears trichomonas was present, in 4--bacteria and fungi, and in one--trichomonas and fungi. After the treatment in control examinations I and II the number of the isolated bacterial strains was lower, trichomonas was no longer present, and the number of fungi was reduced evidently. In the light of these microbiological examinations Gynalgin was found to exert a strong fungicidal, bactericidal and antitrichomonal activity, and the results of laboratory investigations agreed with those of clinical trials of Gynalgin effectiveness.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Antifungal Agents/administration & dosage , Antitrichomonal Agents/administration & dosage , Bacterial Infections/drug therapy , Candidiasis, Vulvovaginal/drug therapy , Chlorquinaldol/administration & dosage , Metronidazole/administration & dosage , Trichomonas Vaginitis/drug therapy , Vulvovaginitis/drug therapy , Animals , Anti-Infective Agents, Local/pharmacology , Antifungal Agents/pharmacology , Antitrichomonal Agents/pharmacology , Bacterial Infections/complications , Bacterial Infections/microbiology , Bacterial Infections/parasitology , Candida albicans/drug effects , Candidiasis, Vulvovaginal/complications , Candidiasis, Vulvovaginal/microbiology , Candidiasis, Vulvovaginal/parasitology , Chlorquinaldol/pharmacology , Drug Combinations , Escherichia coli/drug effects , Female , Gram-Positive Bacteria/drug effects , Humans , In Vitro Techniques , Metronidazole/pharmacology , Trichomonas Vaginitis/complications , Trichomonas Vaginitis/microbiology , Trichomonas Vaginitis/parasitology , Trichomonas vaginalis/drug effects , Vulvovaginitis/complications , Vulvovaginitis/microbiology , Vulvovaginitis/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...